Soeda Y, Hayashi E, Nakatani N, Ishigaki S, Takaichi Y, Tachibana T
Sci Rep. 2024; 14(1):16391.
PMID: 39060263
PMC: 11282240.
DOI: 10.1038/s41598-024-65949-7.
Fereydouni-Forouzandeh P, Canet G, Diego-Diaz S, Rocaboy E, Petry S, Whittington R
Methods Mol Biol. 2024; 2754:309-321.
PMID: 38512673
DOI: 10.1007/978-1-0716-3629-9_16.
Goedert M, Crowther R, Scheres S, Spillantini M
Cytoskeleton (Hoboken). 2023; 81(1):95-102.
PMID: 38073060
PMC: 7615684.
DOI: 10.1002/cm.21812.
Bloom G, Baas P
Cytoskeleton (Hoboken). 2023; 81(1):7-9.
PMID: 37638689
PMC: 10840720.
DOI: 10.1002/cm.21783.
Ferrer I
Free Neuropathol. 2023; 3.
PMID: 37284149
PMC: 10209894.
DOI: 10.17879/freeneuropathology-2022-3806.
Common and Specific Marks of Different Tau Strains Following Intra-Hippocampal Injection of AD, PiD, and GGT Inoculum in hTau Transgenic Mice.
Ferrer I, Andres-Benito P, Carmona M, Del Rio J
Int J Mol Sci. 2022; 23(24).
PMID: 36555581
PMC: 9787745.
DOI: 10.3390/ijms232415940.
Proteomic analysis of heat-stable proteins revealed an increased proportion of proteins with compositionally biased regions.
Park H, Yamanaka T, Nukina N
Sci Rep. 2022; 12(1):4347.
PMID: 35289333
PMC: 8921518.
DOI: 10.1038/s41598-022-08044-z.
Alzheimer's disease - the journey of a healthy brain into organ failure.
Golde T
Mol Neurodegener. 2022; 17(1):18.
PMID: 35248124
PMC: 8898417.
DOI: 10.1186/s13024-022-00523-1.
Tau: A Signaling Hub Protein.
Mueller R, Combs B, Alhadidy M, Brady S, Morfini G, Kanaan N
Front Mol Neurosci. 2021; 14:647054.
PMID: 33815057
PMC: 8017207.
DOI: 10.3389/fnmol.2021.647054.
New Insights Into Drug Discovery Targeting Tau Protein.
Soeda Y, Takashima A
Front Mol Neurosci. 2020; 13:590896.
PMID: 33343298
PMC: 7744460.
DOI: 10.3389/fnmol.2020.590896.
Tau Filament Self-Assembly and Structure: Tau as a Therapeutic Target.
Oakley S, Maina M, Marshall K, Al-Hilaly Y, Harrington C, Wischik C
Front Neurol. 2020; 11:590754.
PMID: 33281730
PMC: 7688747.
DOI: 10.3389/fneur.2020.590754.
Compound screening in cell-based models of tau inclusion formation: Comparison of primary neuron and HEK293 cell assays.
Crowe A, Henderson M, Anderson J, Titus S, Zakharov A, Simeonov A
J Biol Chem. 2020; 295(12):4001-4013.
PMID: 32034092
PMC: 7086036.
DOI: 10.1074/jbc.RA119.010532.
Impaired tau-microtubule interactions are prevalent among pathogenic tau variants arising from missense mutations.
Xia Y, Sorrentino Z, Kim J, Strang K, Riffe C, Giasson B
J Biol Chem. 2019; 294(48):18488-18503.
PMID: 31653695
PMC: 6885647.
DOI: 10.1074/jbc.RA119.010178.
Assembly of transgenic human P301S Tau is necessary for neurodegeneration in murine spinal cord.
Macdonald J, Bronner I, Drynan L, Fan J, Curry A, Fraser G
Acta Neuropathol Commun. 2019; 7(1):44.
PMID: 30885267
PMC: 6421678.
DOI: 10.1186/s40478-019-0695-5.
The role of annealing and fragmentation in human tau aggregation dynamics.
Huseby C, Bundschuh R, Kuret J
J Biol Chem. 2019; 294(13):4728-4737.
PMID: 30745358
PMC: 6442056.
DOI: 10.1074/jbc.RA118.006943.
Human neuroblastoma SH-SY5Y cells treated with okadaic acid express phosphorylated high molecular weight tau-immunoreactive protein species.
Boban M, Babic Leko M, Miskic T, Hof P, Simic G
J Neurosci Methods. 2018; 319:60-68.
PMID: 30278184
PMC: 6440880.
DOI: 10.1016/j.jneumeth.2018.09.030.
Reconsideration of Amyloid Hypothesis and Tau Hypothesis in Alzheimer's Disease.
Kametani F, Hasegawa M
Front Neurosci. 2018; 12:25.
PMID: 29440986
PMC: 5797629.
DOI: 10.3389/fnins.2018.00025.
Multimodal Imaging in Rat Model Recapitulates Alzheimer's Disease Biomarkers Abnormalities.
Parent M, Zimmer E, Shin M, Kang M, Fonov V, Mathieu A
J Neurosci. 2017; 37(50):12263-12271.
PMID: 29097597
PMC: 5729194.
DOI: 10.1523/JNEUROSCI.1346-17.2017.
Pathological Tau Strains from Human Brains Recapitulate the Diversity of Tauopathies in Nontransgenic Mouse Brain.
Narasimhan S, Guo J, Changolkar L, Stieber A, McBride J, Silva L
J Neurosci. 2017; 37(47):11406-11423.
PMID: 29054878
PMC: 5700423.
DOI: 10.1523/JNEUROSCI.1230-17.2017.
GFP-Mutant Human Tau Transgenic Mice Develop Tauopathy Following CNS Injections of Alzheimer's Brain-Derived Pathological Tau or Synthetic Mutant Human Tau Fibrils.
Gibbons G, Banks R, Kim B, Xu H, Changolkar L, Leight S
J Neurosci. 2017; 37(47):11485-11494.
PMID: 28986461
PMC: 5700428.
DOI: 10.1523/JNEUROSCI.2393-17.2017.